Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.500
0.00 (0.00%)
At close: Feb 26, 2026, 4:00 PM EST
1.548
+0.048 (3.22%)
After-hours: Feb 26, 2026, 6:30 PM EST

Lexicon Pharmaceuticals Revenue

Lexicon Pharmaceuticals had revenue of $14.18M in the quarter ending September 30, 2025, with 710.40% growth. This brings the company's revenue in the last twelve months to $70.86M, up 1,255.21% year-over-year. In the year 2024, Lexicon Pharmaceuticals had annual revenue of $31.08M with 2,481.48% growth.

Revenue (ttm)
$70.86M
Revenue Growth
+1,255.21%
P/S Ratio
9.07
Revenue / Employee
$688,000
Employees
103
Market Cap
640.63M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202431.08M29.88M2,481.48%
Dec 31, 20231.20M1.07M766.19%
Dec 31, 2022139.00K-159.00K-53.36%
Dec 31, 2021298.00K-23.70M-98.76%
Dec 31, 202024.00M-298.08M-92.55%
Dec 31, 2019322.07M258.86M409.54%
Dec 31, 201863.21M-28.48M-31.06%
Dec 31, 201791.69M12.43M15.69%
Dec 31, 201679.26M-50.76M-39.04%
Dec 31, 2015130.01M107.16M468.89%
Dec 31, 201422.85M20.63M928.53%
Dec 31, 20132.22M1.13M104.04%
Dec 31, 20121.09M-760.00K-41.10%
Dec 31, 20111.85M-3.06M-62.33%
Dec 31, 20104.91M-5.79M-54.13%
Dec 31, 200910.70M-21.62M-66.89%
Dec 31, 200832.32M-17.80M-35.51%
Dec 31, 200750.12M-22.68M-31.15%
Dec 31, 200672.80M-2.88M-3.81%
Dec 31, 200575.68M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Rigel Pharmaceuticals282.08M
Fulcrum Therapeutics80.00M
MeiraGTx Holdings27.42M
Ocugen5.37M
YD Bio510.36K
Allogene Therapeutics22.00K
Revenue Rankings